September 30, 2017 - By Migdalia James
Analysts expect Mindray Medical International Ltd (ADR) (NYSE:MR) to report $0.26 EPS on November, 3.They anticipate $0.01 EPS change or 3.70% from last quarter’s $0.27 EPS. T_MR’s profit would be $30.80 million giving it 26.87 P/E if the $0.26 EPS is correct. After having $0.27 EPS previously, Mindray Medical International Ltd (ADR)’s analysts see -3.70% EPS growth. It closed at $27.94 lastly. It is down 0.00% since September 30, 2016 and is . It has underperformed by 16.70% the S&P500.
Among 13 analysts covering O2 (ETR:O2D), 7 have Buy rating, 2 Sell and 4 Hold. Therefore 54% are positive. O2 had 32 analyst reports since June 23, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, July 22 by HSBC. Bankhaus Lampe maintained the stock with “Hold” rating in Saturday, January 16 report. The company was maintained on Friday, July 24 by Jefferies. The stock has “Buy” rating by Berenberg on Tuesday, November 10. As per Wednesday, November 18, the company rating was upgraded by HSBC. DZ-Bank AG downgraded the stock to “Sell” rating in Thursday, July 30 report. UBS upgraded the shares of O2D in report on Wednesday, October 21 to “Buy” rating. Berenberg upgraded the shares of O2D in report on Tuesday, September 1 to “Buy” rating. Commerzbank upgraded the stock to “Add” rating in Tuesday, July 21 report. The stock has “Buy” rating by Nomura on Thursday, October 22. See Telefonica Deutschland Holding AG (ETR:O2D) latest ratings:
Telefonica Deutschland Holding AG is a Germany firm engaged in the telecommunication industry. The company has market cap of 14.12 billion EUR. The Firm offers mobile and fixed-line services providing voice, data and other services to retail and business customers. It currently has negative earnings. It also acts as a wholesale provider, offering access to its infrastructure and service capabilities to its wholesale partners.
The stock decreased 0.29% or EUR 0.01 on September 29, reaching EUR 4.75. About 1.54M shares traded. Telefonica Deutschland Holding AG (ETR:O2D) has 0.00% since September 30, 2016 and is . It has underperformed by 16.70% the S&P500.
Mindray Medical International Limited is a developer, maker and marketer of medical devices across the world. The company has market cap of $3.31 billion. The Firm operates in three divisions: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. It has a 18.8 P/E ratio. The Company’s patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.